A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib-Reference-Cited by-同舟云学术

A novel thyroid function index associated with opposite therapeutic outcomes in advanced hepatocellular carcinoma patients receiving chemotherapy or sorafenib

Published:2018-05-21 Issue:5 Volume:14 Page:e341-e351
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Chu Yu-De¹,Lin Kwang-Huei²,Huang Ya-Hui¹,Lin Chen-Chun¹,Hung Chien-Fu³,Yeh Ta-Sen⁴,Lee Wei-Chen⁴,Yeh Chau-Ting¹⁵^ORCID

Affiliation:

1. Liver Research Center; Chang Gung Memorial Hospital; Taoyuan Taiwan

2. Department of Biochemistry, School of Medicine; Chang-Gung University; Taoyuan Taiwan

3. Department of Diagnosis Radiology; Chang Gung Memorial Hospital; Taipei Taiwan

4. Department of General Surgery; Chang Gung Memorial Hospital; Taoyuan Taiwan

5. Molecular Medicine Research Center; Chang Gung University; Taoyuan Taiwan

Funder

Chang Gung Memorial Hospital, Linkou

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12983/fullpdf

Reference26 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Hepatocellular carcinoma epidemiology;Bosetti;Best Pract Res Clin Gastroenterol,2014

3. Hepatocellular carcinoma review: current treatment, and evidence-based medicine;Karaman;World J Gastroenterol,2014

4. Treatment of hepatocellular carcinoma: a systematic review;Lin;Liver Cancer,2012

5. Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review;Nishikawa;Anticancer Res,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithyroid drug-induced leukopenia and G-CSF administration: a long-term cohort study;Scientific Reports;2023-11-07

2. Thyroid Dysfunction from Treatments for Solid Organ Cancers;Endocrinology and Metabolism Clinics of North America;2022-06

Use of a Novel Thyroid-Stimulating Hormone Model for Predicting the Progression of Hepatocellular Carcinoma

;OncoTargets and Therapy;2020-11

4. The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells;Cells;2020-07-20

5. Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance;Frontiers in Medicine;2020-05-22